Stay updated on Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page.

Latest updates to the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a newer site build with no substantive changes to the study details visible on the page.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page’s footer revision/version was updated from v3.5.2 to v3.5.3, indicating a site release update without changing the displayed study details.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision notes updated to add v3.5.0 and remove v3.4.3.SummaryDifference0.1%

- Check76 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check105 days agoChange DetectedA new Revision: v3.4.2 is displayed and an earlier government-funding status notice was removed. The study content, eligibility criteria, and outcome measures remain unchanged.SummaryDifference0.4%

Stay in the know with updates to Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page.